-
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausalwomen with steroid hormone receptor-positive breast cancer : the BIG 1-98 randomised clinical trial at 8.1 years median follow-upRegan, Meredith M. ...Background: Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine ... therapies for this patient population need extended follow-up. We present an update of efficacy outcomes in the Breast International Group (BIG) 1-98 study at 8 1 years median follow-up. Methods: BIG 1-98 is a randomised, phase 3, double-blind trial of postmenopausal women with hormone receptor-positive early breast cancer that compares 5 years of tamoxifen or letrozole monotherapy, or sequential treatment with 2 years of one of these drugs followed by 3 years of the other.Randomisation was done with permuted blocks, and stratified according tothe two-arm or four-arm randomisation option, participating institution, andchemotherapy use. Patients, investigators, data managers, and medical reviewers were masked. The primary efficacy endpoint was disease-free survival(events were invasive breast cancer relapse, second primaries šcontralateral breast and non-breastđ, or death without previous cancer event). Secondary endpoints were overall survival, distant recurrence-free interval (DRFI), and breast cancer-free interval (BCFI). The monotherapy comparison included patients randomly assigned to tamoxifen or letrozole for 5years. In 2005, after a significant disease-free survival benefit was reported for letrozole as compared with tamoxifen, a protocol amendment facilitated the crossover to letrozole of patients who were still receiving tamoxifen alone; Cox models and Kaplan-Meier estimates with inverse probability of censoring weighting (IPCW) are used to account for selective crossover to letrozole of patients (n=619) in the tamoxifen arm. (Abstract truncated at 2000 characters)Source: The lancet oncology. - ISSN 1470-2045 (Vol. 12, iss. 12, 2011, str. 1101-1108)Type of material - article, component partPublish date - 2011Language - englishCOBISS.SI-ID - 29393113
Author
Regan, Meredith M. |
Neven, Patrick |
Giobbie-Hurber, Anita
Other authors
Čufer, Tanja, 1955-
Topics
Breast Neoplasms |
Drug Therapy |
Tamoxifen |
Postmenopause |
Receptors, Estrogen |
Receptors, Progesterone |
Disease-Free Survival |
Survival Analysis |
Double-Blind Method |
Clinical Trials, Phase Iii |
Dojka, novotvorbe |
Tamoksifen |
Pomenopavza |
Receptorji progesteronski |
Receptorji estrogenski |
Preživetje, analiza |
Dvojnoslepa metoda |
Brez bolezni, preživetje |
Klinična raziskava, faza III
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Regan, Meredith M. | ![]() |
Neven, Patrick | ![]() |
Giobbie-Hurber, Anita | ![]() |
Čufer, Tanja, 1955- | 12179 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.